These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 30118857

  • 1. Risk Factors for Restenosis after Drug-coated Balloon Angioplasty for Complex Femoropopliteal Arterial Occlusive Disease.
    Roh JW, Ko YG, Ahn CM, Hong SJ, Shin DH, Kim JS, Kim BK, Choi D, Hong MK, Jang Y.
    Ann Vasc Surg; 2019 Feb; 55():45-54. PubMed ID: 30118857
    [Abstract] [Full Text] [Related]

  • 2. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
    Schmidt A, Piorkowski M, Görner H, Steiner S, Bausback Y, Scheinert S, Banning-Eichenseer U, Staab H, Branzan D, Varcoe RL, Scheinert D.
    JACC Cardiovasc Interv; 2016 Apr 11; 9(7):715-24. PubMed ID: 27056311
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Critical appraisal of paclitaxel balloon angioplasty for femoral-popliteal arterial disease.
    Herten M, Torsello GB, Schönefeld E, Stahlhoff S.
    Vasc Health Risk Manag; 2016 Apr 11; 12():341-56. PubMed ID: 27621646
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Primary Patency of Long-Segment Femoropopliteal Artery Lesions in Patients with Peripheral Arterial Occlusive Disease Treated with Paclitaxel-Eluting Technology.
    Phair J, Carnevale M, Lipsitz EC, Shariff S, Scher L, Garg K.
    Ann Vasc Surg; 2020 Jul 11; 66():595-600. PubMed ID: 31863948
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
    Shammas NW, Shammas GA, Jones-Miller S, Shammas WJ, Bou-Dargham B, Shammas AN, Banerjee S, Rachwan RJ, Daher GE.
    Cardiovasc Revasc Med; 2018 Oct 11; 19(7 Pt A):771-777. PubMed ID: 30420096
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Predictors of recurrence after paclitaxel drug-coated balloon use for treating femoropopliteal in-stent restenosis.
    Taha AG, Saleh MI, Ali H, Gamal WM.
    Vascular; 2024 Aug 11; 32(4):834-841. PubMed ID: 36896828
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
    Tepe G, Schroeder H, Albrecht T, Reimer P, Diehm N, Baeriswyl JL, Brechtel K, Speck U, Zeller T.
    J Endovasc Ther; 2020 Apr 11; 27(2):276-286. PubMed ID: 32096451
    [Abstract] [Full Text] [Related]

  • 17. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
    Iida O, Soga Y, Urasawa K, Saito S, Jaff MR, Wang H, Ookubo H, Yokoi H, MDT-2113 SFA Japan Investigators.
    J Endovasc Ther; 2018 Feb 11; 25(1):109-117. PubMed ID: 29264999
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Midterm Outcomes of Drug-Coated Balloon Angioplasty in Femoropopliteal Lesions in a Daily Practice Cohort.
    Nugteren M, Serné A, Verhoeven B, Koning O, van den Haak R, Scholtes V, Hinnen JW.
    Ann Vasc Surg; 2020 Apr 11; 64():188-197. PubMed ID: 31634609
    [Abstract] [Full Text] [Related]

  • 20. Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study.
    Schroeder H, Meyer DR, Lux B, Ruecker F, Martorana M, Duda S.
    Catheter Cardiovasc Interv; 2015 Aug 11; 86(2):278-86. PubMed ID: 25708850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.